China Biologic Products EBITDA margin
Cos'è EBITDA margin di China Biologic Products?
EBITDA margin di China Biologic Products Holdings, Inc. è 42.45%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Miscellaneous settore su LSE rispetto a China Biologic Products
Aziende con ebitda margin simili a China Biologic Products
- Legacy Housing ha EBITDA margin di 42.33%
- Amerigo Resources ha EBITDA margin di 42.34%
- ACNB ha EBITDA margin di 42.36%
- Pharos plc ha EBITDA margin di 42.37%
- Lilis ha EBITDA margin di 42.40%
- Silvercorp Metals ha EBITDA margin di 42.44%
- China Biologic Products ha EBITDA margin di 42.45%
- United Overseas Bank (Singapore) ha EBITDA margin di 42.46%
- First Bancshares Inc Miss ha EBITDA margin di 42.50%
- WEC Inc ha EBITDA margin di 42.51%
- National Grid Plc ha EBITDA margin di 42.51%
- PetroShale ha EBITDA margin di 42.52%
- Divi's Laboratories ha EBITDA margin di 42.52%